News | October 23, 2023
KKR to invest in life sciences firm Catalio Capital Management
Investment is additive to KKR’s existing health care growth strategy
Investment is additive to KKR’s existing health care growth strategy
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Prateek has more than 23 years of rich experience in Human Resource
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Subscribe To Our Newsletter & Stay Updated
